Danaher Corp

NYSE: DHR
$250.41
-$2.70 (-1.1%)
Closing price April 24, 2024
Danaher Corporation is a global powerhouse in the design, manufacture, and marketing of a wide range of professional, medical, industrial, and commercial products and services. With a strong focus on biotechnology, life sciences, and diagnostics, Danaher offers everything from bioprocess technologies and consumables to advanced diagnostic systems and genomic medicines. The company's portfolio includes well-known brands like Beckman Coulter, Pall, and Leica Microsystems, catering to the development and manufacture of therapeutics, lab automation, and healthcare filtration solutions. Founded in 1969 and headquartered in Washington, D.C., Danaher has evolved into a key player in advancing scientific research and healthcare.
The corporate spreads in U.S. corporate bonds are now low enough, on top of record-low interest rates, that companies would be foolish to ignore the opportunity to grab vast amounts of capital on the...
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
If there is one former Dow Jones industrial average leader that is in need of serious help, look no further than General Electric.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Caterpillar, CenturyLink, Danaher, Dillard's, Intel, Intelsat, Mattel, ONEOK, PG&E and Windstream.
Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences biotechnology instrument division to Danaher is one of those fairy...
Monday was a positive day for the broad U.S. markets. As this week goes on we are looking forward to some more major retailers posting their quarterly results. Crude oil backed off in the session....
Medical device maker Danaher has agreed to acquire GE's biopharma business for $21.4 billion in cash. The transaction is expected to be completed by the end of this year.
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators...
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall Street feel that is...
Managers of the UBS Q-GARP portfolio continue searching for high-quality U.S. growth companies that are trading at attractive valuations. They maintain that recent volatility in the market has had no...
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
The top analyst upgrades, downgrades and other research calls from Tuesday include Amgen, Caterpillar, Dollar General, Duke Energy, General Electric, Honeywell, 3M, Netflix and Sprint.
The top analyst upgrades, downgrades and other research calls from Wednesday include Check Point Software, Coca-Cola, Kraft Heinz, PepsiCo and UnitedHealth.
Analysts at Merrill Lynch have made a big move by adding a top consumer goods stock and a life sciences company to the firm's well-respected US 1 list of stocks, while removing a utility stock.
It is not uncommon for an acquirer to see its shares drop on news when it makes an acquisition. Still, when investors see both companies rise on a merger announcement then they automatically assume...